title: [Radiologic implantation of central venous portal systems in the forearm].
abstract: OBJECTIVE
  To assess the safety and effectiveness of fluoroscopic guided brachial implanted central-venous miniport systems.
  
  
  METHODS
  In 32 oncological patients a central-venous miniport system (Vital-Port, CPC-Cook) was implanted in the forearm. The group included 15 women and 17 men (range 33-78, mean 56 years).
  
  
  RESULTS
  Technical success was 100%, in 6 patients vasospasm produced difficulties in catheter placement. In a total of 2878 patients days (range 3-445, mean 90 days) 5 complications occurred (15.6%, 1.7 on 1,000 catheterdays): In one patient (3.13%, 0.35/ 1000 d) the system was changed due to leakage of the catheter near the chamber. Four patients had minor complications: in one case excision of a suture line granuloma was necessary, one haematoma at the site of the chamber was treated with dressing, one patient had a wound dehiscence and one occluded catheter returned to patency by flushing the system with contrast material. Venous thrombosis, phlebitis, catheter dislocation, paravasation or system-related infection did not occur.
  
  
  CONCLUSIONS
  Fluoroscopic guided peripheral central-venous port implantation is a safe and easy procedure with a high success rate and a low complication rate which can be performed in an outpatient setting.
authors.affiliation: Institut für Röntgendiagnostik, Klinikum der Universität Regensburg.
authors.forename: M
authors.initials: M
authors.lastname: Lenhart
authors.forename: M
authors.initials: M
authors.lastname: Chegini
authors.forename: J
authors.initials: J
authors.lastname: Gmeinwieser
authors.forename: C
authors.initials: C
authors.lastname: Manke
authors.forename: S
authors.initials: S
authors.lastname: Feuerbach
mesh_terms: D000328:Adult; D000368:Aged; D002405:Catheterization, Central Venous / Q000009:adverse effects; D004868:Equipment Failure; D005260:Female; D005471:Fluoroscopy / Q000009:adverse effects / Q000379:methods*; D005542:Forearm; D006099:Granuloma; D006406:Hematoma; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000628:therapy*; D013997:Time Factors; D014652:Vascular Diseases / Q000209:etiology